STTrading Long weekend thread 8th, 9th and 10th of June 2024, page-29

Commodities didn’t like that yield spike, or maybe Chinese inventories?

The transaction size question is fundamental, surprised it doesn’t get more airtime, good to see it’s being discussed.

Couple of bios that would go not astray on a quality WL for the forum to ponder, all about a good time to be aware of these codes in their model lifecycle.

CYC, IP proven and has been sold into the euro’s for years, awarded FDA approval sept 2023 and last month awarded ‘pass through’ status by the yanks, a code that initiates reimbursement in the US healthcare system.
Had a CR recently for funds to facilitate US push @ 140, coming off a long downtrend, very much under the radar. What I like about it is their capital management, SOI minimal only 100m or so, got a bit of the FND about it, any positive update the illiquidity will magnify the upside.
They also have a history of buybacks with any spare cash, if you’re a SH a good sign.
Garage got in other week @ 140ish.

IMM, the next TLX? Big call but some of the bio guys I know are more than keen.
Been around for years as bio’s tend to do but about to initiate a stage 3 trial in conjunction with Merck (Keytruda), Merck and IMM sharing costs and numbers are big, they are playing with the big boys. They are in the immunotherapy space.
Just did a CR for $100m or so to fund their half at @38, we tried to get some on market but it never came back down, been in a strong but subdued uptrend before that.
We still don’t hold but will and daughter been holding small exposure for years although only sitting on small green, all about timing and patience with bios.
Here’s a 3 year chart, always good to take a long view on these long leadtime  bios to get a handle on whats going on, been in a sustained but slow uptrend for some time, the recent CR effect obvious.